Description
COVID-19 EMERGENCY -DIASORIN COVID-19 TEST KITS
First action · last action
2020-04-07 · 2022-03-24
Transactions
5
First transaction's obligation
$325,696
Base + all options value (sum of deltas)
$538,046
Extent competed
NOT COMPETED
Other than full & open authority
URGENCY (FAR 6.302-2)
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 5 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-04-07+$325,696= $325,696
- Mod P000012020-07-28+$211,500= $537,196
- Mod P000022020-08-05+$0= $537,196
- Mod P000032020-11-18+$861= $538,057
- Mod P000042022-03-24-$11= $538,046
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-04-07 | +$325,696 | $325,696 | COVID-19 EMERGENCY -DIASORIN COVID-19 TEST KITS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2020-07-28 | +$211,500 | $537,196 | COVID-19 EMERGENCY -DIASORIN COVID-19 TEST KITS |
| Mod P00002· OTHER ADMINISTRATIVE ACTION | 2020-08-05 | +$0 | $537,196 | COVID-19 EMERGENCY -DIASORIN COVID-19 TEST KITS |
| Mod P00003· FUNDING ONLY ACTION | 2020-11-18 | +$861 | $538,057 | COVID-19 EMERGENCY -DIASORIN COVID-19 TEST KITS |
| Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2022-03-24 | −$11 | $538,046 | COVID-19 EMERGENCY -DIASORIN COVID-19 TEST KITS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI FGK2QR959BV5)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24926N0641 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $172,138 | FY2026 |
| 36C24426N0964 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $45,218 | FY2026 |
| 36C24426A0041 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · Q999 · MEDICAL- OTHER | $0 | FY2026 |
| 36C24426N0963 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $244,586 | FY2026 |
| 36C26026N0382 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · Q301 · REFERENCE LABORATORY TESTING | $125,000 | FY2026 |
| 36C24426N0738 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $78,181 | FY2026 |
Other recipients under 6640 from 241-NETWORK CONTRACT OFFICE 01 (36C241) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C24126P0510 | CYTEK BIOSCIENCES, INC. | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $531,939 | FY2026 |
| 36C24126F0116 | FISHER SCIENTIFIC COMPANY L.L.C. | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $51,256 | FY2026 |
| 36C24126N0682 | WERFEN USA LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $48,410 | FY2026 |
| 36C24126N0717 | WERFEN USA LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $67,510 | FY2026 |
| 36C24126N0665 | WERFEN USA LLC | 241-NETWORK CONTRACT OFFICE 01 (36C241) | $66,505 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C24120P0582_3600_-NONE-_-NONE- · retrieved 2026-09-26.